Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,418
Platelet-rich Fibrin and Grooving for Sagittal Split Osteotomy
for
Inferior Alveolar Nerve Injury, Nerve Injury,
Location: Seattle WA
Sponsor: Jesse Han
Sex: All
Age: 18+
Code: NCT04706182
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Seattle WA, Vancouver, Vancouver WA, Eugene OR, Calgary,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase3, Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
for
Advanced Melanoma
Location: Seattle WA, Edmonton, Salt Lake City UT, Los Angeles CA,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT06112314
Phase3, Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
for
Hematologic Disorder, Bleeding Disorder,
Location: Seattle WA, Sacramento CA, Oakland CA, San Francisco CA,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Seattle WA, Portland OR, Boise ID, Sacramento CA,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701669
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
for
Von Willebrand Disease (VWD)
Location: Seattle WA, Sacramento CA, San Francisco CA,
Sponsor: Vega Therapeutics, Inc
Sex: All
Age: 12 - 70+
Code: NCT07115004
Phase3, Recruiting
Von Willebrand Factor in Pregnancy (VIP) Study
for
Von Willebrand Diseases
Location: Seattle WA, Salt Lake City UT, Aurora CO, Peoria IL,
Sponsor: University of Washington
Sex: Female
Age: 18+
Code: NCT04146376
Recruiting
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
for
Hemophilia A, Hemophilia B
Location: Seattle WA, Edmonton, Hamilton, Philadelphia PA,
Sponsor: Pfizer
Sex: Male
Age: 1 - 70+
Code: NCT05145127
Phase3, Recruiting
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
for
Von Willebrand Diseases
Location: Seattle WA, Sacramento CA, Los Angeles CA, Aurora CO,
Sponsor: Vega Therapeutics, Inc
Sex: All
Age: 12 - 60
Code: NCT05776069
Phase1, Phase2, Recruiting
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
for
Hemophilia A
Location: Seattle WA, San Diego CA, San Antonio TX
Sponsor: Washington Institute for Coagulation
Sex: Male
Age: 16+
Code: NCT04131036
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
for
Systemic Lupus Erythematosus,
Location: Seattle WA, Aurora CO, Scottsdale AZ, Rochester MN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT06570798
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
for
Arthritis, Psoriatic
Location: Seattle WA, Glendale AZ, Mesa AZ, Albuquerque NM,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06807424
Phase3, Recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
for
Von Willebrand Disease (VWD),
Location: Seattle WA, Portland OR, Los Angeles CA, Phoenix AZ,
Sponsor: Hemab ApS
Sex: All
Age: 16+
Code: NCT06610201
Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma